Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial is a research paper published in Nature Medicine (2021). On theSindex it has a DataRank of 2.3. It has been cited 104 times, with 77 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.698
From this paper's citation signal
Citation Network Contribution
1.6
From 59 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 77 citers.
Bill and Melinda Gates Foundation
Grant: OPP1107669
Bill and Melinda Gates Foundation
Grant: OPP1146996
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI149670, AI145801, AI129797, AI128751, AI126603, AI124377, OD024917
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI114381
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI106408
National Institutes of Health
Grant: 1R01AI129797-01
Optimization of Broadly Neutralizing Antibodies for HIV Eradication
National Institutes of Health
Grant: 5R37AI028433-13
Immune System Modeling/HIV
National Institutes of Health
Grant: 5P01AI131365-02
Viral dynamics of rebound and control following early treatment of HIV/SIV
National Institutes of Health
Grant: 5R01AI149670-03
Single-Cell Analysis of the HIV/SIV Reservoir
National Institutes of Health
Grant: 5R01OD011095-28
Modeling Viral and T Lymphocyte Dynamics
National Institutes of Health
Grant: 5U01AI145801-06
Ad26 Based Therapeutic Vaccines for HIV
National Institutes of Health
Grant: 1UM1AI126603-01
Combined Immunologic Approaches to Cure HIV-1
National Institutes of Health
Grant: 5UM1AI124377-02
Consortia for Innovative AIDS Research in Nonhuman Primates
National Institutes of Health
Grant: 5U19AI128751-05
Development of Ad26/Env Vaccines for HIV
Fields of Study
Keywords
Sustainable Development Goals